Skip to main content

Public Policy

By Emily Olsen | 11:13 am | March 03, 2023
Scott Loughlin, partner at Hogan Lovells, discusses the Federal Trade Commission's recent enforcement action against GoodRx and what digital health companies should learn from the case.
By Emily Olsen | 01:58 pm | March 02, 2023
In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.
By Emily Olsen | 11:16 am | March 01, 2023
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
By Emily Olsen | 01:24 pm | February 27, 2023
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.
By Emily Olsen | 03:45 pm | February 24, 2023
The organizations said Medicare Advantage members in 24 counties will have access to the rural provider's services.
By Jessica Hagen | 02:39 pm | February 22, 2023
Rapid RV/LV uses AI to calculate the ratio between the right and left ventricles, an indicator of pulmonary embolism severity.
By Jessica Hagen | 11:28 am | February 17, 2023
Heather Meade, principal at Washington Council Ernst & Young, discusses the potential effects on digital health companies and patients following the end of the COVID-19 public health emergency.
By Emily Olsen | 12:17 pm | February 10, 2023
According to the state authorities, the online birth control company billed Medi-Cal for services it didn't provide and dispensed female condoms to beneficiaries who didn't request them.
By Emily Olsen | 12:46 pm | February 08, 2023
The deal is expected to close this year.
By Emily Olsen | 01:35 pm | February 07, 2023
According to reporting by the Wall Street Journal, CVS is closing in on an agreement to acquire the primary care chain for $10.5 billion including debt.